• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Moffitt Cancer Center Partners with Cryoport

    CONTRACTPHARMA

    First Patient Enrolled in STK11 Lung Cancer Phase I at Moffitt

    GLOBENEWSWIRE

    Moffitt and Fulgent Pharma partner on personalised cancer therapies

    PHARMACEUTICAL TECHNOLOGY

    Moffitt, Fulgent Pharma Partner To Revolutionize Cancer Therapeutics

    BUSINESSWIRE

    Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial

    CLINICALTRIALSARENA

    Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance

    PRNEWSWIRE

    Moffitt Researchers Identify New Relevant Target for PARP Inhibitor Talazoparib

    NEWSWISE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.